2026 Agenda

Time

Topic

Speaker

Moderator: Trevor Feinstein, MD

8:00 – 8:10 AM

Welcome and Day Overview

• Suresh S. Ramalingam, MD. FACP, FASCO

Thoracic Cancer

8:10 – 8:25 AM

Optimal Frontline Therapy in Metastatic NSCLC Driver Negative: What’s Next?

• Shirish M. Gadgeel, MBBS, FASCO

8:25 – 8:45 AM

DEBATE
Treatment of Acquired Resistance in 2L EGFR-Mutant Advanced NSCLC: Treatment Should Be Mechanism-based

8:25 – 8:33 AM

Yes

• Kelsey Pan, MD, MPH

8:33 – 8:41 AM

No

• Jennifer W. Carlisle, MD

8:41 – 8:45 AM

Rebuttals and Discussion

8:45 – 9:00 AM

Updates in Mutation-Driven NSCLC

• Suresh S. Ramalingam, MD. FACP, FASCO

9:00 – 9:20 AM

DEBATE
Should We Perform MRD Testing in Patients With Resectable NSCLC in the Postoperative Setting?

9:00 – 9:08 AM

Yes

• Conor E. Steuer, MD

9:08 – 9:16 AM

No

• Hirva Mamdani, MD

9:16 – 9:20 AM

Rebuttals and Discussion

9:20 – 9:35 AM

Updates in the Treatment of SCLC

• Ticiana Leal, MD

9:35 – 9:55 AM

Patient-based Multidisciplinary Panel Discussion With ASCO Highlights and Q&A

All speakers

Pt case presented by Winship fellow

9:55 – 10:15 AM

BREAK

Head and Neck

10:15–10:30 AM

Immunotherapy in Advanced Head and Neck Cancers: State of the Art

• Nabil Saba, MD, FACP

10:30 – 10:50 AM

DEBATE
Postoperative Deintensification Is Needed When Preoperative Immunotherapy Is Administered

10:30 – 10:38 AM

Pro

• Azeem S. Kaka, MD

10:38 – 10:46 AM

Con

• Sujith Baliga, MD

10:46 – 10:50 AM

Rebuttals and Discussion

10:50 – 11:10 AM

Patient-based Panel Discussion With ASCO Highlights and Q&A

All speakers

Pt case presented by Winship fellow

Lecture of the Day

11:10 – 11:40 AM

GLP-1 Agonists in Cancer Therapy

• Neil M. Iyengar, MD

11:40 AM – 12:30 PM

LUNCH

Moderator: Devi Sampat, MD

Leukemia

12:30 – 12:45 PM

Is Intensive Chemotherapy On Its Way Out for Frontline Treatment of AML?

• Martha Arellano, MD

12:45 – 1:05 PM

DEBATE
Should NPM1 FLT3-ITD Co-Mutated AML Be Transplanted in First Remission?

12:45 – 12:53 PM

Pro

• Colin A. Vale, MD

12:53 – 1:01 PM

Con

• Amelia A. Langston, MD

1:01 – 1:05 PM

Rebuttals and Discussion

1:05 – 1:20 PM

Moving the Bar in MPNs

• Anthony M. Hunter, MD

1:20 – 1:35 PM

Sequencing Anemia Therapies in LR-MDS

• Nikolaos Papadantonakis, MD, PhD, MSc

1:35 – 1:50 PM

Current Treatment Strategies for Ph-Positive B-ALL

• Hagop M. Kantarjian, MD

1:50 – 2:05 PM

The Role of BCL-2 Inhibitors in the Treatment of Higher-Risk MDS

• Michael Hochman, MD

2:05 – 2:25 PM

Patient-based Panel Discussion With EHA Highlights and Q&A

All speakers

Pt case presented by Winship fellow

2:25 PM

Closing Comments and Adjourn

• Sagar Lonial, MD, FACP, FASCO

6:00 – 8:00 PM

Welcome Dinner at Beach Club (Name badges required for entry)

Time

Topic

Speaker

Moderator: Kristina Bowen, MD

7:30 – 7:35 AM

Welcome and Day Overview

• Suresh Ramalingam, MD, FACP, FASCO

Breast Cancer

7:35 – 7:50 AM

The Role of ctDNA in the Management of Early-stage Breast Cancer

• Shipra Gandhi, MD, MS

7:50 – 8:05 AM

ADCs in Breast Cancer: The Present and the Future

• Manali Bhave, MD

8:05 – 8:20 AM

Novel Agents for ER+ Disease

• Kevin Kalinsky, MD, MS, FASCO

8:20 – 8:40 AM

DEBATE
Axillary Surgery Is No Longer Needed for Clinically Node-negative, Postmenopausal Patients

8:20 – 8:28 AM

Yes

• Mylin Torres, MD

8:28 – 8:36 AM

No

• Cletus Arciero, MD, FACS

8:36 – 8:40 AM

Rebuttals and Discussion

8:40 – 8:55 AM

De-Escalation of Therapy in Early-stage Breast Cancer: When Can Less Be More?

• Jane Lowe Meisel, MD, FASCO

8:55 – 9:15 AM

DEBATE
Should Radiation Be Recommended for Older Patients With Early-stage Breast Cancer?

8:55 – 9:03 AM

Yes

• Reshma Jagsi, MD, DPhil

9:03 – 9:11 AM

No

• Tari A. King, MD, FACS, FSSO, FASCO

9:11 – 9:15 AM

Rebuttals and Discussion

9:15 – 9:35 AM

Patient-based Panel Discussion With ASCO Highlights and Q&A

All speakers

Pt case presented by Winship fellow

9:35 – 9:55 AM

Break

Lecture of the Day

9:55 – 10:25 AM

Leadership in Medicine

• Fadlo R. Khuri, MD

Melanoma

10:25 – 10:40 AM

Optimal Treatment of Early-stage Melanoma

• Michael C. Lowe, MD, MA

10:40 – 11:00 AM

DEBATE
Sentinel Node Biopsy Is Standard of Care

10:40 – 10:48 AM

Yes

• Nathaniel R. Wilson, MD

10:48 – 10:56 AM

No

• Melissa A. Wilson, MD, PhD

10:56 – 11:00 AM

Rebuttals and Discussion

Brain Cancers

11:00 – 11:15 AM

Proton vs Photon Radiation Therapy in the Treatment of Central Nervous System Tumors

• Zachary S. Buchwald, MD, PhD

11:15 – 11:30 AM

Advancements in Molecular Diagnostics and Targeted Therapy for Central Nervous System Tumors

• Edjah K. Ndoum, MD, FAANS

11:30 – 11:50 AM

DEBATE
Grade 3 IDH-Mutated Gliomas: Is IDH Inhibitor SOC?

11:30 – 11:38 AM

Yes

• Byram Ozer, MD, PhD

11:38 – 11:46 AM

No

• Laura Donovan, MD

11:46 – 11:50 AM

Rebuttals and Discussion

11:50 AM – 12:30 PM

Lunch

Moderator: Jamie M. Goldman, MD

Lymphoma

12:30 – 12:45 PM

Management of Newly Diagnosed CLL

• Susan M. O’Brien, MD

12:45 – 1:00 PM

Novel Therapies for Relapsed CLL

• Andres Chang, MD, PhD

1:00 – 1:15 PM

Optimal Sequencing of Therapies for Patients With Relapsed/Refractory DLBCL

• Dipenkumar Modi, MD

1:15 – 1:30 PM

Update on Novel Targeted Therapies in Relapsed Mantle Cell Lymphoma

• Jonathon B. Cohen, MD, MS

1:30 – 1:45 PM

What Is the Right Time for CAR T-cell Therapy in Patients With Relapsed Low-grade NHL and CLL

• Jean Koff, MD, MS

1:45 – 2:05 PM

DEBATE
Rituximab + Lenalidomide vs Rituximab + Lenalidomide + X for Relapsed Follicular Lymphoma

1:45 – 1:53 PM

R+Len

• Michael A. Schneider, MD, PhD

1:53 – 2:01 PM

R+Len+X

• Jean Koff, MD, MS

2:01 – 2:05 PM

Rebuttals and Discussion

2:05 – 2:25 PM

Patient-based Panel Discussion With EHA Highlights and Q&A

All speakers

Pt case presented by Winship fellow

2:25 PM

Closing Comments and Adjourn

• Sagar Lonial, MD, FACP, FASCO

2:30 PM

Georgia Blood Cancer Trials Network Meeting | Open to all

• Jonathon B. Cohen, MD, MS

Time

Topic

Speaker

Moderator: Mark A. Taylor, MD

8:00 – 8:05 AM

Welcome and Day Overview

• Suresh Ramalingam, MD, FACP FASCO

Multiple Myeloma

8:05 – 8:25 AM

DEBATE
Newly Diagnosed Multiple Myeloma: Triplets vs Quadruplets in Elderly Patients

8:05 – 8:13 AM

Triplets

• Nisha Joseph, MD

8:13 – 8:21 AM

Quadruplets

• Jonathan L. Kaufman, MD

8:21 – 8:25 AM

Rebuttals and Discussion

8:25 – 8:40 AM

Treating MM in 2026: Is There a Path to Cure?

• Sagar Lonial, MD, FACP, FASCO

8:40 – 8:55 AM

Prioritizing the Target: GPRC5D vs BCMA

• Ajay K. Nooka, MD, MPH, FACP

8:55 – 9:10 AM

Bispecific Antibodies for Early Relapsed MM

• Roberto Mina, MD

9:10 – 9:25 AM

Updates in Smoldering MM

• Nisha Joseph, MD

9:25 – 9:40 AM

Enhancing Immunotherapy in Myeloma

• Kenneth C. Anderson, MD

9:40 – 10:00 AM

Patient-Based Panel Discussion With EHA Highlights and Q&A

All speakers

Pt case presented by Winship fellow

10:00 – 10:20 AM

Break

Lecture of the Day

10:20 – 10:45 AM

Infectious Complications of CAR T-cell Therapy and Bispecific Antibodies

• Amelia A. Langston, MD

Gynecologic Cancers and Sarcoma

10:45 – 11:00 AM

Evolving Treatment Strategies in Endometrial Cancer

• Kristen D. Starbuck, MD

11:00 – 11:15 AM

Locally Advanced Cervical Cancer: Evolving Treatment Paradigms

• Ann Oluloro, MD, MPH, FACOG

11:15 – 11:30 AM

Ovarian Cancer Treatment in the Post-PARP Era

• Jennifer M. Scalici, MD

11:30 – 11:50 AM

Joint GYN and Sarcoma Patient-Based Panel Discussion With ASCO Highlights and Q&A

All speakers

Pt case presented by Winship fellow

11:50 AM – 12:30 PM

Lunch

Moderator: Bradley T. Sumrall, MD

Gastrointestinal Cancers

12:30 – 12:45 PM

The Changing Landscape of Pancreatic Cancer Therapy

• Olumide B. Gbolahan, MBBS, MSc

12:45 – 1:00 PM

Recent Advances in the Management of Metastatic Colorectal Cancer

• Olatunji B. Alese, MD, FASCO

1:00 – 1:20 PM

DEBATE
Choice of Systemic Therapy After Durvalumab + FLOT for Gastroesophageal Cancer

1:00 – 1:08 PM

IO + Chemotherapy

• Oluwadunni Emiloju, MBBS, MS

1:08 – 1:16 PM

VEGF + Chemotherapy

• Lindsay M. Hannan, MD, MSc

1:16 – 1:20 PM

Rebuttals and Discussion

1:20 – 1:35 PM

Early Onset GI Cancers

• Karishma Kodia, MD

1:35 – 1:50 PM

Current and Emerging Blood-Based Biomarkers

• Daniel M. Halperin, MD

1:50 – 2:10 PM

Multidisciplinary Patient-based Panel Discussion With ASCO Highlights and Q&A

All speakers

Pt case presented by Winship fellow

2:10 PM

Closing Comments and Adjourn

• Sagar Lonial, MD, FACP, FASCO

5:00 – 6:30 PM

Closing Reception at Beach Club | (Name badges required for entry)

Time

Topic

Speaker

Moderator: Josh Simmons, MD, FACP

8:00 – 8:05 AM

Welcome and Day Overview

• Suresh Ramalingam, MD, FACP, FASCO

Genitourinary Cancer

8:05 – 8:25 AM

DEBATE
Neoadjuvant/Adjuvant Enfortumab Vedotin (EV) + Pembrolizumab Should Replace Cisplatin in Muscle-Invasive Bladder Cancer (MIBC)

8:05 – 8:13 AM

Yes

• Jacqueline Brown, MD

8:13 – 8:21 AM

No

• Jordan Ciuro, MD

8:21 – 8:25 AM

Rebuttals and Discussion

8:25 – 8:40 AM

What’s on the Menu for Metastatic Urothelial Cancer?

• Bradley C. Carthon, MD, PhD

8:40 – 8:55 AM

Treatment Updates in Metastatic Prostate Cancer

• Jacob E. Berchuck, MD

8:55 – 9:05 AM

What’s New in Renal Cell Carcinoma (RCC) Treatment?

• Shahid S. Ahmed, MBBS

9:05 – 9:20 AM

Using AI to Accelerate Trial Accrual At Your Site: Where Are We?

• Ravi B. Parikh, MD, MPP, FACP

9:20 – 9:40 AM

Patient-based Panel Discussion With ASCO Highlights and Q&A

All speakers

Pt case presented by Winship fellow

9:40 – 9:45 AM

Closing Comments and Adjourn

• Suresh Ramalingam, MD, FACP, FASCO
• Sagar Lonial, MD, FACP, FASCO